Cargando…

Overdue to understand anticoagulation in pulmonary arterial hypertension

Detalles Bibliográficos
Autores principales:	Parikh, Kishan S., Gray, Michael P., Rubin, Lewis J., Badesch, David, Krasuski, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858629/ https://www.ncbi.nlm.nih.gov/pubmed/29534640 http://dx.doi.org/10.1177/2045893217743184

Ejemplares similares

An Overdue Brain Death Assessment of Traumatic Brain Injury Patients: Review of Malaysian Medical Council 2006 Documentations
por: Zakaria, Zaitun
Publicado: (2023)

Understanding the perspective of patients with pulmonary arterial hypertension: looking beyond health-related quality of life
por: Aguirre-Camacho, Aldo
Publicado: (2021)

Overdue assignment : taking responsibility for Canada's schools /
por: Lewington, Jennifer
Publicado: (1993)

Anesthetic management of pediatric with congenital heart disease with pulmonary hypertension
por: Singh, Dipika, et al.
Publicado: (2014)

Pulmonary arterial hypertension incidence in Latvia in 2019
por: Kaulins, Ricards, et al.
Publicado: (2022)

A long overdue pleasure
por: Liu, Xiehe
Publicado: (2012)

A long overdue ban
por: Vaughan, Adam
Publicado: (2020)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

“Neuroacanthocytosis” – Overdue for a Taxonomic Update
por: Walker, Ruth H., et al.
Publicado: (2021)

4DCT is long overdue for improvement
por: Tryggestad, Erik, et al.
Publicado: (2023)

Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016)

Are anticoagulants still indicated in pulmonary arterial hypertension?
por: Olschewski, Horst, et al.
Publicado: (2018)

Response to “Noninvasive determinants of pulmonary hypertension (PH) in interstitial lung disease (ILD)” by Joseph et al.
por: Parikh, Raj, et al.
Publicado: (2023)

Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection
por: Sahay, Sandeep, et al.
Publicado: (2020)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Preoperative pulmonary artery hypertension as a risk factor: the tip of the iceberg
por: Engin, Mesut, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Pulmonary hypertension secondary to takayasu’s arteritis: management using a combined medical and interventional approach
por: Nitzberg, Matthew, et al.
Publicado: (2020)

Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis
por: Parikh, Kishan S., et al.
Publicado: (2017)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
por: Ahn, Kyung Jin, et al.
Publicado: (2019)

Early Intervention in Psychosis: Obvious, Effective, Overdue
por: McGorry, Patrick D.
Publicado: (2015)

Streamlined manuscript submission guidelines: Beyond overdue
por: Sobani, Zain A., et al.
Publicado: (2017)

Anticoagulation in pulmonary arterial hypertension: a decision analysis
por: Jose, Arun, et al.
Publicado: (2019)

Novel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte growth factor be beneficial?
por: Guo, Ying-Hua, et al.
Publicado: (2012)

Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
por: Chebib, Nader, et al.
Publicado: (2017)

Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension
por: Kalemci, Serdar, et al.
Publicado: (2019)

The physiological basis of pulmonary arterial hypertension
por: Naeije, Robert, et al.
Publicado: (2022)

Pulmonary paracoccidioidomycosis‐induced pulmonary hypertension
por: Batah, Sabrina Setembre, et al.
Publicado: (2020)

Pulmonary Arterial Hypertension—Symptoms and Impact Questionnaire: feasibility of utilizing one-day versus seven-day symptom reporting
por: Frantz, Robert P., et al.
Publicado: (2020)

RE: Pulmonary Hypertension Associated with Use of Phentermine?
por: Hendricks, Ed J., et al.
Publicado: (2011)

Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?”
por: Fernandes, Timothy M., et al.
Publicado: (2020)

Interpretation of a new biomarker for the right ventricle introduced to evaluate the severity of pulmonary arterial hypertension
por: Kerkhof, Peter L.M., et al.
Publicado: (2019)

Ameliorated nailfold capillary morphology of patients with pulmonary arterial hypertension in systemic sclerosis, treated with riociguat
por: Sugimoto, Tomohiro, et al.
Publicado: (2023)

Pulmonary artery hypertension in mitral stenosis: Role of right ventricular stroke volume, atrio-ventricular compliance, and pulmonary venous compliance
por: Neema, Praveen Kumar, et al.
Publicado: (2012)

Overfat and Underfat: New Terms and Definitions Long Overdue
por: Maffetone, Philip B., et al.
Publicado: (2017)

Long‐Overdue Guidelines for the Cord Blood Banking Community
por: Broxmeyer, Hal E.
Publicado: (2019)

Neonatal Jaundice and Autism: Precautionary Principle Invocation Overdue
por: Wilde, Vera K
Publicado: (2022)

Provinces and Territories Are Overdue for an Update in Healthcare Funding Policies
por: Sutherland, Jason M.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q6lu6vondklng5udq9c1e24hmp